Clustered regularly interspaced short palindromic repeats (CRISPR)–CRISPR-associated protein 13 (Cas13) has been rapidly developed for nucleic-acid-based diagnostics by using its characteristic ...
Rapid-results testing has become an increasingly important part of our fast-paced world. Utilizing droplet microfluidics allows for quicker point-of-care testing (POCT) but is not always as accurate, ...
Back in the bad old days, dealing with DNA and RNA in a lab setting was often fraught with peril. Detection technologies were limited to radioisotopes and hideous chemicals like ethidium bromide, a ...
A collaborative biosensing system is developed for amplification-free RNA/miRNA detection by integrating Type III CRISPR-Cas10 system with a graphene field-effect transistor (GFET). Continuous ...
Co-Diagnostics Inc, a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced that the Australian Patent Office has granted ...
Lateral flow assays (LFAs), such as the COVID-19 rapid test, are powerful devices to rapidly detect a protein’s presence or absence. This assay is so easy to perform that it enables at-home testing, ...
Infectious diseases (IDs) still take 14 million lives worldwide each year, making up a quarter of total deaths. This makes them a leading cause of mortality. The management of IDs is dependent on ...
There has been incredible progress in the discovery and application of molecular biomarkers for multiple pathologies, including cancer and neurodegenerative diseases. Because biomarkers for precision ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback